Putative dehydrogenase tms1 suppresses growth arrest induced by a p53 tumour mutant in fission yeast.

Expression of a human tumour-derived p53 His 273 cDNA induced growth arrest in fission yeast Schizosaccharomyces pombe. Based on the p53-induced growth arrest, we cloned an extragenic suppressor, termed tms1, by complementation. The open reading frame of the tms1 gene corresponded to a protein of 347 amino acids with a calculated mass of 37380 Da. The transcriptional start site of the tms1 gene was mapped and, in addition, the corresponding cDNA was isolated and expressed in Escherichia coli. Recombinant tms1 protein served as an antigen to produce specific polyclonal antibodies to aid identification of the tms1-gene-product in total yeast lysates. Comparison of the deduced amino acid sequence of tms1 with available databases revealed significant similarity to dehydrogenases, suggesting that the tms1 protein itself might possess dehydrogenase activity.

[1]  K Meyer-Siegler,et al.  A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[3]  L. Pinna.  Casein kinase 2: an 'eminence grise' in cellular regulation? , 1990, Biochimica et biophysica acta.

[4]  A. Feinberg,et al.  Concerted nonsyntenic allelic loss in human colorectal carcinoma. , 1988, Science.

[5]  D. Beach,et al.  Human p53 inhibits growth in Schizosaccharomyces pombe , 1992, Molecular and cellular biology.

[6]  R. Weinberg,et al.  The action of oncogenes in the cytoplasm and nucleus. , 1985, Science.

[7]  J. Jenkins,et al.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.

[8]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Jörnvall,et al.  Sorbitol dehydrogenase. The primary structure of the sheep-liver enzyme. , 1984, European journal of biochemistry.

[10]  A. Caswell,et al.  Interaction of glyceraldehyde-3-phosphate dehydrogenase with isolated microsomal subfractions of skeletal muscle. , 1985, Journal of Biological Chemistry.

[11]  L. Old,et al.  Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[13]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[14]  D. Pantaloni,et al.  Bundling of microtubules by glyceraldehyde-3-phosphate dehydrogenase and its modulation by ATP. , 1985, European journal of biochemistry.

[15]  S. Moreno,et al.  Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. , 1991, Methods in enzymology.

[16]  G. Thomas,et al.  Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas , 1988, International journal of cancer.

[17]  J. Willey,et al.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[19]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[20]  A. Bernstein,et al.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus , 1985, Nature.

[21]  H. Khorana.  Rhodopsin, photoreceptor of the rod cell. An emerging pattern for structure and function. , 1992, The Journal of biological chemistry.

[22]  B. Hall,et al.  The primary structure of the alcohol dehydrogenase gene from the fission yeast Schizosaccharomyces pombe. , 1983, The Journal of biological chemistry.

[23]  P. Nurse,et al.  Vectors for the construction of gene banks and the integration of cloned genes in Schizosaccharomyces pombe and Saccharomyces cerevisiae. , 1986, Plasmid.

[24]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[25]  M. Montenarh,et al.  Association of casein kinase II with immunopurified p53. , 1991, Oncogene.

[26]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[27]  B. Vallee,et al.  Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.

[28]  S. Reed,et al.  Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast , 1991, Cell.

[29]  J. Jiménez,et al.  Complementation of fission yeast cdc2ts and cdc25ts mutants identifies two cell cycle genes from Drosophila: a cdc2 homologue and string. , 1990, The EMBO journal.

[30]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[31]  Y. Nakamura,et al.  VNTR (variable number of tandem repeats) markers show loss of chromosome 17p sequences in human colorectal carcinomas. , 1988, Cytogenetics and cell genetics.

[32]  F. Sherman,et al.  DNA sequence required for efficient transcription termination in yeast , 1982, Cell.

[33]  Jonathan A. Cooper.  Oncogenes and anti-oncogenes. , 1990, Current opinion in cell biology.

[34]  C. Heizmann,et al.  Glyceraldehyde‐3‐Phosphate Dehydrogenase Is a Nonhistone Protein and a Possible Activator of Transcription in Neurons , 1986, Journal of neurochemistry.

[35]  P. Nurse,et al.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2 , 1987, Nature.

[36]  A. Levine,et al.  Growth regulation of a cellular tumour antigen, p53, in nontransformed cells , 1984, Nature.

[37]  P. Friedman,et al.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[39]  J. Jenkins,et al.  Mouse p53 inhibits SV40 origin-dependent DNA replication , 1987, Nature.

[40]  U. Leupold.  Chapter 8 Genetical Methods for Schizosaccharomyces pombe , 1970 .

[41]  T. Maimets,et al.  p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. , 1990, Oncogene.

[42]  J. Jenkins,et al.  The cellular oncogene p53 can be activated by mutagenesis , 1985, Nature.

[43]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[44]  J. Milner,et al.  SV40-53K antigen: a possible role for 53K in normal cells. , 1981, Virology.

[45]  C. Finlay,et al.  The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth , 1993, Molecular and cellular biology.

[46]  Paul Russell,et al.  cdc25 + functions as an inducer in the mitotic control of fission yeast , 1986, Cell.

[47]  P. Wagner,et al.  The ras-related YPT1 gene product in yeast: A GTP-binding protein that might be involved in microtubule organization , 1986, Cell.

[48]  A. Levine,et al.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.

[49]  S. Benchimol,et al.  Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. , 1988, Oncogene.

[50]  P. Wagner,et al.  Biochemical properties of the ras‐related YPT protein in yeast: a mutational analysis. , 1987, The EMBO journal.

[51]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[52]  P. Wagner,et al.  A human tumour-derived mutant p53 protein induces a p34cdc2 reversible growth arrest in fission yeast. , 1991, Oncogene.

[53]  K. Gould,et al.  Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase , 1990, Science.